Cargando…

Platelet-derived growth factor (PDGF)-BB regulates the airway tone via activation of MAP2K, thromboxane, actin polymerisation and Ca(2+)-sensitisation

BACKGROUND: PDGFR-inhibition by the tyrosine kinase inhibitor (TKI) nintedanib attenuates the progress of idiopathic pulmonary fibrosis (IPF). However, the effects of PDGF-BB on the airway tone are almost unknown. We studied this issue and the mechanisms beyond, using isolated perfused lungs (IPL) o...

Descripción completa

Detalles Bibliográficos
Autores principales: Rieg, Annette D., Suleiman, Said, Anker, Carolin, Bünting, Nina A., Verjans, Eva, Spillner, Jan, Kalverkamp, Sebastian, von Stillfried, Saskia, Braunschweig, Till, Uhlig, Stefan, Martin, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287894/
https://www.ncbi.nlm.nih.gov/pubmed/35841089
http://dx.doi.org/10.1186/s12931-022-02101-x
_version_ 1784748348273590272
author Rieg, Annette D.
Suleiman, Said
Anker, Carolin
Bünting, Nina A.
Verjans, Eva
Spillner, Jan
Kalverkamp, Sebastian
von Stillfried, Saskia
Braunschweig, Till
Uhlig, Stefan
Martin, Christian
author_facet Rieg, Annette D.
Suleiman, Said
Anker, Carolin
Bünting, Nina A.
Verjans, Eva
Spillner, Jan
Kalverkamp, Sebastian
von Stillfried, Saskia
Braunschweig, Till
Uhlig, Stefan
Martin, Christian
author_sort Rieg, Annette D.
collection PubMed
description BACKGROUND: PDGFR-inhibition by the tyrosine kinase inhibitor (TKI) nintedanib attenuates the progress of idiopathic pulmonary fibrosis (IPF). However, the effects of PDGF-BB on the airway tone are almost unknown. We studied this issue and the mechanisms beyond, using isolated perfused lungs (IPL) of guinea pigs (GPs) and precision-cut lung slices (PCLS) of GPs and humans. METHODS: IPL: PDGF-BB was perfused after or without pre-treatment with the TKI imatinib (perfused/nebulised) and its effects on the tidal volume (TV), the dynamic compliance (Cdyn) and the resistance were studied. PCLS (GP): The bronchoconstrictive effects of PDGF-BB and the mechanisms beyond were evaluated. PCLS (human): The bronchoconstrictive effects of PDGF-BB and the bronchorelaxant effects of imatinib were studied. All changes of the airway tone were measured by videomicroscopy and indicated as changes of the initial airway area. RESULTS: PCLS (GP/human): PDGF-BB lead to a contraction of airways. IPL: PDGF-BB decreased TV and Cdyn, whereas the resistance did not increase significantly. In both models, inhibition of PDGFR-(β) (imatinib/SU6668) prevented the bronchoconstrictive effect of PDGF-BB. The mechanisms beyond PDGF-BB-induced bronchoconstriction include activation of MAP2K and TP-receptors, actin polymerisation and Ca(2+)-sensitisation, whereas the increase of Ca(2+) itself and the activation of EP(1–4)-receptors were not of relevance. In addition, imatinib relaxed pre-constricted human airways. CONCLUSIONS: PDGFR regulates the airway tone. In PCLS from GPs, this regulatory mechanism depends on the β-subunit. Hence, PDGFR-inhibition may not only represent a target to improve chronic airway disease such as IPF, but may also provide acute bronchodilation in asthma. Since asthma therapy uses topical application. This is even more relevant, as nebulisation of imatinib also appears to be effective.
format Online
Article
Text
id pubmed-9287894
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92878942022-07-17 Platelet-derived growth factor (PDGF)-BB regulates the airway tone via activation of MAP2K, thromboxane, actin polymerisation and Ca(2+)-sensitisation Rieg, Annette D. Suleiman, Said Anker, Carolin Bünting, Nina A. Verjans, Eva Spillner, Jan Kalverkamp, Sebastian von Stillfried, Saskia Braunschweig, Till Uhlig, Stefan Martin, Christian Respir Res Research BACKGROUND: PDGFR-inhibition by the tyrosine kinase inhibitor (TKI) nintedanib attenuates the progress of idiopathic pulmonary fibrosis (IPF). However, the effects of PDGF-BB on the airway tone are almost unknown. We studied this issue and the mechanisms beyond, using isolated perfused lungs (IPL) of guinea pigs (GPs) and precision-cut lung slices (PCLS) of GPs and humans. METHODS: IPL: PDGF-BB was perfused after or without pre-treatment with the TKI imatinib (perfused/nebulised) and its effects on the tidal volume (TV), the dynamic compliance (Cdyn) and the resistance were studied. PCLS (GP): The bronchoconstrictive effects of PDGF-BB and the mechanisms beyond were evaluated. PCLS (human): The bronchoconstrictive effects of PDGF-BB and the bronchorelaxant effects of imatinib were studied. All changes of the airway tone were measured by videomicroscopy and indicated as changes of the initial airway area. RESULTS: PCLS (GP/human): PDGF-BB lead to a contraction of airways. IPL: PDGF-BB decreased TV and Cdyn, whereas the resistance did not increase significantly. In both models, inhibition of PDGFR-(β) (imatinib/SU6668) prevented the bronchoconstrictive effect of PDGF-BB. The mechanisms beyond PDGF-BB-induced bronchoconstriction include activation of MAP2K and TP-receptors, actin polymerisation and Ca(2+)-sensitisation, whereas the increase of Ca(2+) itself and the activation of EP(1–4)-receptors were not of relevance. In addition, imatinib relaxed pre-constricted human airways. CONCLUSIONS: PDGFR regulates the airway tone. In PCLS from GPs, this regulatory mechanism depends on the β-subunit. Hence, PDGFR-inhibition may not only represent a target to improve chronic airway disease such as IPF, but may also provide acute bronchodilation in asthma. Since asthma therapy uses topical application. This is even more relevant, as nebulisation of imatinib also appears to be effective. BioMed Central 2022-07-15 2022 /pmc/articles/PMC9287894/ /pubmed/35841089 http://dx.doi.org/10.1186/s12931-022-02101-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Rieg, Annette D.
Suleiman, Said
Anker, Carolin
Bünting, Nina A.
Verjans, Eva
Spillner, Jan
Kalverkamp, Sebastian
von Stillfried, Saskia
Braunschweig, Till
Uhlig, Stefan
Martin, Christian
Platelet-derived growth factor (PDGF)-BB regulates the airway tone via activation of MAP2K, thromboxane, actin polymerisation and Ca(2+)-sensitisation
title Platelet-derived growth factor (PDGF)-BB regulates the airway tone via activation of MAP2K, thromboxane, actin polymerisation and Ca(2+)-sensitisation
title_full Platelet-derived growth factor (PDGF)-BB regulates the airway tone via activation of MAP2K, thromboxane, actin polymerisation and Ca(2+)-sensitisation
title_fullStr Platelet-derived growth factor (PDGF)-BB regulates the airway tone via activation of MAP2K, thromboxane, actin polymerisation and Ca(2+)-sensitisation
title_full_unstemmed Platelet-derived growth factor (PDGF)-BB regulates the airway tone via activation of MAP2K, thromboxane, actin polymerisation and Ca(2+)-sensitisation
title_short Platelet-derived growth factor (PDGF)-BB regulates the airway tone via activation of MAP2K, thromboxane, actin polymerisation and Ca(2+)-sensitisation
title_sort platelet-derived growth factor (pdgf)-bb regulates the airway tone via activation of map2k, thromboxane, actin polymerisation and ca(2+)-sensitisation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287894/
https://www.ncbi.nlm.nih.gov/pubmed/35841089
http://dx.doi.org/10.1186/s12931-022-02101-x
work_keys_str_mv AT riegannetted plateletderivedgrowthfactorpdgfbbregulatestheairwaytoneviaactivationofmap2kthromboxaneactinpolymerisationandca2sensitisation
AT suleimansaid plateletderivedgrowthfactorpdgfbbregulatestheairwaytoneviaactivationofmap2kthromboxaneactinpolymerisationandca2sensitisation
AT ankercarolin plateletderivedgrowthfactorpdgfbbregulatestheairwaytoneviaactivationofmap2kthromboxaneactinpolymerisationandca2sensitisation
AT buntingninaa plateletderivedgrowthfactorpdgfbbregulatestheairwaytoneviaactivationofmap2kthromboxaneactinpolymerisationandca2sensitisation
AT verjanseva plateletderivedgrowthfactorpdgfbbregulatestheairwaytoneviaactivationofmap2kthromboxaneactinpolymerisationandca2sensitisation
AT spillnerjan plateletderivedgrowthfactorpdgfbbregulatestheairwaytoneviaactivationofmap2kthromboxaneactinpolymerisationandca2sensitisation
AT kalverkampsebastian plateletderivedgrowthfactorpdgfbbregulatestheairwaytoneviaactivationofmap2kthromboxaneactinpolymerisationandca2sensitisation
AT vonstillfriedsaskia plateletderivedgrowthfactorpdgfbbregulatestheairwaytoneviaactivationofmap2kthromboxaneactinpolymerisationandca2sensitisation
AT braunschweigtill plateletderivedgrowthfactorpdgfbbregulatestheairwaytoneviaactivationofmap2kthromboxaneactinpolymerisationandca2sensitisation
AT uhligstefan plateletderivedgrowthfactorpdgfbbregulatestheairwaytoneviaactivationofmap2kthromboxaneactinpolymerisationandca2sensitisation
AT martinchristian plateletderivedgrowthfactorpdgfbbregulatestheairwaytoneviaactivationofmap2kthromboxaneactinpolymerisationandca2sensitisation